AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 58 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $27,829,000 | +179.1% | 1,360,818 | +104.7% | 0.01% | +150.0% |
| Q3 2016 | $9,971,000 | +48.0% | 664,746 | +6.8% | 0.00% | +100.0% |
| Q2 2016 | $6,736,000 | +86.3% | 622,563 | +133.5% | 0.00% | 0.0% |
| Q1 2016 | $3,615,000 | -30.3% | 266,606 | -5.1% | 0.00% | 0.0% |
| Q4 2015 | $5,184,000 | -22.9% | 280,954 | +5.7% | 0.00% | -50.0% |
| Q3 2015 | $6,728,000 | – | 265,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |